| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
DocGo (NASDAQ:DCGO) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.12) by 5.17...
DocGo (NASDAQ:DCGO) narrows FY2025 sales outlook from $300.000 million-$330.000 million to $315.000 million-$320.000 million vs...
DocGo Inc. (Nasdaq: DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health an...
Strategic Acquisition Combines DocGo's Last Mile Healthcare Delivery Capabilities With SteadyMD's Virtual Care Platform...
Canaccord Genuity analyst Richard Close maintains DocGo (NASDAQ:DCGO) with a Hold and raises the price target from $1.45 to ...